September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Corneal epithelial thickness mapping in the diagnosis of ocular surface pathologies involving the corneal epithelium.
Author Affiliations & Notes
  • Sara Touhami
    Ophthalmology, Quinze-Vingts Hospital, Paris, France
  • Cristina Georgeon
    Ophthalmology, Quinze-Vingts Hospital, Paris, France
  • Nacim Bouheraoua
    Ophthalmology, Quinze-Vingts Hospital, Paris, France
  • Laurent Laroche
    Ophthalmology, Quinze-Vingts Hospital, Paris, France
  • Vincent Borderie
    Ophthalmology, Quinze-Vingts Hospital, Paris, France
  • Footnotes
    Commercial Relationships   Sara Touhami, None; Cristina Georgeon, None; Nacim Bouheraoua, None; Laurent Laroche, None; Vincent Borderie, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1916. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sara Touhami, Cristina Georgeon, Nacim Bouheraoua, Laurent Laroche, Vincent Borderie; Corneal epithelial thickness mapping in the diagnosis of ocular surface pathologies involving the corneal epithelium.. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1916.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To analyze the value of corneal epithelial thickness mapping (CETM) by Fourier-domain optical coherence tomography (OCT) in the diagnosis and differentiation of ocular surface pathologies involving the corneal epithelium.

Methods : Study type:Cross-sectional.
Patients:Consecutive patients with ocular surface pathology involving the corneal epithelium who underwent CETM by Fourier-domain OCT at a tertiary center (Quinze-Vingts Hospital, Paris) were included.For each patient, CETM parameters were compared between the groups using Fisher-exact and one-way ANOVA tests in order to look for distinctive features for each pathology.

Results : 171 eyes of 171 patients were included between January 2013 and September 2015. Mean age at inclusion was 46.2 years. Patients distribution was as follows: 32.1% were healthy, 15.2% had limbal deficiency (LD), 7% had trachoma, 15.8% had epithelial basement membrane dystrophy (EBMD), 1.2% had herpes, 1.2% had dry eye syndrome, 20.5% had keratoconus (KC), 3% had Thygeson’s superficial punctuate keratitis, 1.8% had superior limbic keratoconjunctivitis and 1.8% had in situ carcinoma. Analysis of CETM revealed specific patterns for various pathologies. A “rayon de roue” aspect of CETM, corresponding to a circular succession of thickened and thinned epithelial areas, seemed specific of LD (72% versus 4% for LD versus all others respectively, p= 4e-8). “Pyramid” aspect of CETM involving triangularly thickened epithelium seemed specific of EBMD (74% versus 2%, p=2e-8). “Donut” aspect of CETM with temporally thickened epithelium, surrounding areas of thinned epithelium seemed suggestive of KC (34.3% versus 1.4%, p=6.4e-8). Other CETM parameters seemed distinctive of LD (LD versus all others respectively): minimal and maximal epithelial thicknesses (ET) (27.4 versus 44.3 microns for minimal ET and 77.4 versus 62.4 microns for maximal ET, p=0.0001), epithelium standard deviation (15.1 versus 4.24, p=0.01) and minimal-maximal ET (-49.9 versus -18.3 microns, p= 3.6e-8).

Conclusions : CETM seems to differentiate ocular surface pathologies in a quite reliable manner. Specific epithelial patterns seem suggestive of LD, KC and EBMD. CETM can help characterize ocular surface pathologies that involve the corneal epithelium beyond what is apparent with the clinical examination, providing a non-invasive and easily available tool for diagnosis and monitoring.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×